Literature DB >> 28290032

Intragastric floating drug delivery system of cefuroxime axetil: In vitro evaluation.

Viral F Patel1, Natavarlal M Patel2.   

Abstract

This investigation describes the development of an intragastric drug-delivery system for cefuroxime axetil. The 32 full factorial design was employed to evaluate contribution of hydroxypropyl methyl cellulose (HPMC) K4M/HPMC K100 LV ratio (polymer blend) and sodium lauryl sulfate (SLS) on drug release from HPMC matrices. Tablets were prepared using direct compression technique. Formulations were evaluated for in vitro buoyancy and drug release study using United States Pharmacopeia (USP) 24 paddletype dissolution apparatus using 0.1N HCl as a dissolution medium. Multiple regression analysis was performed for factorial design batches to evaluate the response. All formulations had floating lag times below 2 minutes and constantly floated on dissolution medium for more than 8 hours. It was found that polymer blend and SLS significantly affect the time required for 50% of drug release, percentage drug release at 12 hours, release rate constant, and diffusion exponent (P<.05). Also linear relationships were obtained between the amount of HPMC K100 LV and diffusion exponent as well as release rate constant. Kinetic treatment to dissolution profiles revealed drug release ranges from anomalous transport to case 1 transport, which was mainly dependent on both the independent variables.

Entities:  

Keywords:  factorial design; floating tablets; hydroxypropyl methylcellulose (HPMC); sodium lauryl sulfate (SLS)

Year:  2017        PMID: 28290032      PMCID: PMC2750724          DOI: 10.1208/pt070117

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  12 in total

1.  Design of controlled release delivery systems using a modified pharmacokinetic approach: a case study for drugs having a short elimination half-life and a narrow therapeutic index.

Authors:  Anurag Sood; Ramesh Panchagnula
Journal:  Int J Pharm       Date:  2003-08-11       Impact factor: 5.875

Review 2.  Floating drug delivery systems: a review.

Authors:  Shweta Arora; Javed Ali; Alka Ahuja; Roop K Khar; Sanjula Baboota
Journal:  AAPS PharmSciTech       Date:  2005-10-19       Impact factor: 3.246

3.  Esterase activity toward the diastereomers of cefuroxime axetil in the rat and dog.

Authors:  G L Mosher; J McBee; D B Shaw
Journal:  Pharm Res       Date:  1992-05       Impact factor: 4.200

4.  Pharmacodynamic and pharmacokinetic rationales for the development of an oral controlled-release amoxicillin dosage form.

Authors:  A Hoffman; H D Danenberg; I Katzhendler; R Shuval; D Gilhar; M Friedman
Journal:  J Control Release       Date:  1998-06       Impact factor: 9.776

5.  Influence of food and reduced gastric acidity on the bioavailability of bacampicillin and cefuroxime axetil.

Authors:  D K Sommers; M van Wyk; J Moncrieff; H S Schoeman
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

6.  Nonlinear intestinal absorption kinetics of cefuroxime axetil in rats.

Authors:  N Ruiz-Balaguer; A Nacher; V G Casabo; M Merino
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

7.  Oral cefuroxime axetil: clinical pharmacology and comparative dose studies in urinary tract infection.

Authors:  D H Adams; M J Wood; I D Farrell; C Fox; A P Ball
Journal:  J Antimicrob Chemother       Date:  1985-09       Impact factor: 5.790

8.  The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after food.

Authors:  P E Williams; S M Harding
Journal:  J Antimicrob Chemother       Date:  1984-02       Impact factor: 5.790

9.  The pharmacokinetics of cefuroxime axetil in the sick elderly patient.

Authors:  E Ridgway; K Stewart; G Rai; M C Kelsey; C Bielawska
Journal:  J Antimicrob Chemother       Date:  1991-05       Impact factor: 5.790

10.  Effect of dose and food on the bioavailability of cefuroxime axetil.

Authors:  A Finn; A Straughn; M Meyer; J Chubb
Journal:  Biopharm Drug Dispos       Date:  1987 Nov-Dec       Impact factor: 1.627

View more
  1 in total

1.  Tailoring of Rosuvastatin Calcium and Atenolol Bilayer Tablets for the Management of Hyperlipidemia Associated with Hypertension: A Preclinical Study.

Authors:  Mahmoud M A Elsayed; Moustafa O Aboelez; Mohamed S Mohamed; Reda A Mahmoud; Ahmed A El-Shenawy; Essam A Mahmoud; Ahmed A Al-Karmalawy; Eman Y Santali; Sameer Alshehri; Mahmoud Elkot Mostafa Elsadek; Mohamed A El Hamd; Abd El Hakim Ramadan
Journal:  Pharmaceutics       Date:  2022-08-04       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.